Linagliptin administered as multiple doses in Japanese patients with type 2 diabetes mellitus
Phase of Trial: Phase II
Latest Information Update: 01 Jul 2011
At a glance
- Drugs Linagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Boehringer Ingelheim; Nippon Boehringer Ingelheim
- 01 Jul 2011 Results published in Clinical Therapeutics.
- 05 Nov 2010 New trial record.